Nifty

:

24636.00

Sensex

:

78954.76

11.35 (0.05%)
373.76 (0.48%)

Login

Nifty
Sensex

:
:

24636.00
78954.76

11.35 (0.05%)
373.76 (0.48%)

Novartis India Ltd.

Pharmaceuticals & Drugs - Domestic

Rating :

75/99

BSE: 500672 | NSE: NOVARTIND

Watchlist

NSE BSE

1609.70

06-Aug-2026

Open
High
Low
Previous Close

1637
1681.6
1556
1634.90

Volume
Traded Value (lacs)
52 Week High
52 Week Low

27545
44395105.5
1780
950

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

3,959.29
40.50
5

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

3,291.59
N/A
4.66

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

-6.39
-1.35
-2.02

EBITDA CAGR (%)

10 Years
5 Years
3 Years

11.49
28.90
7.03

PAT CAGR (%)

10 Years
5 Years
3 Years

-6.53
37.01
-0.80

P:E (Median)

8 Years
5 Years
3 Years

30.26
26.68
25.00

P:BV (Average)

8 Years
5 Years
3 Years

2.68
2.81
3.10

EV:EBITDA (Average)

8 Years
5 Years
3 Years

14.19
14.49
14.04

Earnings Forecasts:

(Updated: 01-08-2026)

Description 2026 2027 2028 2029
Adj EPS 54 -9 - -
P/E Ratio 29.81 -178.86 - -
Revenue - - - -
EBITDA - - - -
Net Income - - - -
ROA - - - -
P/B Ratio - - - -
ROE - - - -
FCFF - - - -
FCFF Yield - - - -
Net Debt - - - -
BVPS - - - -

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Jun 26 Jun 25 Var% Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var%
Net Sales 103.81 87.55 18.57% 90.55 83.88 7.95% 85.90 93.00 -7.63% 90.33 87.10 3.71%
Expenses 68.90 60.31 14.24% 69.93 59.97 16.61% 63.54 67.42 -5.75% 66.45 69.14 -3.89%
EBITDA 34.91 27.24 28.16% 20.62 23.91 -13.76% 22.36 25.58 -12.59% 23.88 17.96 32.96%
EBIDTM 33.63% 31.11% 22.77% 28.50% 26.03% 27.51% 26.44% 20.62%
Other Income 8.74 10.61 -17.62% 10.01 10.63 -5.83% 8.75 10.60 -17.45% 9.40 10.32 -8.91%
Interest 0.06 0.10 -40.00% 0.07 0.12 -41.67% 0.98 0.36 172.22% 0.11 0.14 -21.43%
Depreciation 0.42 0.53 -20.75% 0.42 0.53 -20.75% 0.48 0.53 -9.43% 0.52 0.58 -10.34%
PBT 43.17 37.22 15.99% 30.14 33.89 -11.07% 29.65 35.29 -15.98% 32.65 27.56 18.47%
Tax 10.96 9.60 14.17% 4.89 4.59 6.54% 13.56 9.84 37.80% 8.43 7.15 17.90%
PAT 32.21 27.62 16.62% 25.25 29.30 -13.82% 16.09 25.45 -36.78% 24.22 20.41 18.67%
PATM 31.03% 31.55% 27.89% 34.93% 18.73% 27.37% 26.81% 23.43%
EPS 13.04 11.18 16.64% 10.22 11.86 -13.83% 6.51 10.30 -36.80% 9.81 8.26 18.77%

Description Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var% Jun 25 Jun 24 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 370.59 356.27 335.07 378.74 399.87 381.35 438.25 490.68 563.89 656.22 689.77 Net Sales Growth 5.42% 6.33% -11.53% -5.28% 4.86% -12.98% -10.69% -12.98% -14.07% -4.86% Cost Of Goods Sold 207.27 202.82 199.84 201.69 178.14 146.61 182.32 198.65 245.51 306.10 286.31 Gross Profit 163.32 153.45 135.23 177.05 221.73 234.74 255.93 292.03 318.38 350.12 403.46 GP Margin 44.07% 43.07% 40.36% 46.75% 55.45% 61.56% 58.40% 59.52% 56.46% 53.35% 58.49% Total Expenditure 268.82 264.85 269.81 313.66 373.12 355.66 426.51 478.54 572.12 631.70 658.95 Power & Fuel Cost - 0.14 0.18 0.35 0.53 0.53 1.27 1.79 2.56 1.77 4.43 % Of Sales - 0.04% 0.05% 0.09% 0.13% 0.14% 0.29% 0.36% 0.45% 0.27% 0.64% Employee Cost - 18.72 22.96 35.64 101.89 108.51 113.87 117.11 144.53 139.30 156.66 % Of Sales - 5.25% 6.85% 9.41% 25.48% 28.45% 25.98% 23.87% 25.63% 21.23% 22.71% Manufacturing Exp. - 11.08 7.54 15.51 34.49 36.52 39.23 42.21 42.07 49.03 62.35 % Of Sales - 3.11% 2.25% 4.10% 8.63% 9.58% 8.95% 8.60% 7.46% 7.47% 9.04% General & Admin Exp. - 12.44 15.37 17.09 18.61 12.95 23.40 43.28 45.74 45.74 47.65 % Of Sales - 3.49% 4.59% 4.51% 4.65% 3.40% 5.34% 8.82% 8.11% 6.97% 6.91% Selling & Distn. Exp. - 10.58 15.87 27.98 35.66 39.77 53.99 60.29 72.48 75.83 70.74 % Of Sales - 2.97% 4.74% 7.39% 8.92% 10.43% 12.32% 12.29% 12.85% 11.56% 10.26% Miscellaneous Exp. - 9.07 8.05 15.40 3.80 10.77 12.43 15.21 19.23 13.93 70.74 % Of Sales - 2.55% 2.40% 4.07% 0.95% 2.82% 2.84% 3.10% 3.41% 2.12% 4.47% EBITDA 101.77 91.42 65.26 65.08 26.75 25.69 11.74 12.14 -8.23 24.52 30.82 EBITDA Margin 27.46% 25.66% 19.48% 17.18% 6.69% 6.74% 2.68% 2.47% -1.46% 3.74% 4.47% Other Income 36.90 41.96 61.68 58.11 33.55 34.19 36.43 78.40 173.81 71.52 244.55 Interest 1.22 0.77 1.49 1.75 4.83 7.68 6.39 1.59 5.53 0.72 0.21 Depreciation 1.84 2.19 2.61 6.06 9.65 12.16 13.14 3.18 2.53 3.59 3.49 PBT 135.61 130.42 122.84 115.38 45.82 40.04 28.64 85.77 157.52 91.73 271.67 Tax 37.84 29.52 37.65 12.02 -0.10 19.14 18.56 34.00 79.16 34.51 73.38 Tax Rate 27.90% 22.63% 30.65% 10.42% 2.62% 47.80% 64.80% 39.64% 50.25% 37.62% 27.01% PAT 97.77 100.90 85.19 103.36 -3.72 20.90 10.08 51.77 78.36 57.22 198.29 PAT before Minority Interest 97.77 100.90 85.19 103.36 -3.72 20.90 10.08 51.77 78.36 57.22 198.29 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 26.38% 28.32% 25.42% 27.29% -0.93% 5.48% 2.30% 10.55% 13.90% 8.72% 28.75% PAT Growth -4.87% 18.44% -17.58% - - 107.34% -80.53% -33.93% 36.95% -71.14% EPS 39.58 40.85 34.49 41.85 -1.51 8.46 4.08 20.96 31.72 23.17 80.28

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 784.96 744.82 775.66 691.70 711.19 720.73 759.19 733.64 919.64 1,193.58 Share Capital 12.34 12.34 12.34 12.34 12.34 12.34 12.34 12.34 14.07 15.98 Total Reserves 772.62 732.48 763.36 681.58 701.80 711.68 751.10 727.48 913.00 1,184.54 Non-Current Liabilities 696.83 716.25 1,007.77 984.00 1,130.65 99.38 891.47 897.75 827.53 26.47 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 708.90 726.33 998.39 991.58 1,109.57 65.93 909.70 916.30 844.46 45.85 Current Liabilities 426.12 399.83 268.26 334.47 357.26 416.93 367.22 481.74 323.21 204.49 Trade Payables 51.47 61.59 59.67 72.20 55.20 72.60 91.40 106.11 73.22 69.66 Other Current Liabilities 24.83 33.54 38.03 45.34 69.64 132.99 67.62 184.52 63.26 88.94 Short Term Borrowings 0.00 0.02 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Short Term Provisions 349.82 304.68 170.56 216.93 232.42 211.34 208.20 191.11 186.73 45.89 Total Liabilities 1,907.91 1,860.90 2,051.69 2,010.17 2,199.10 1,237.04 2,017.88 2,113.13 2,070.38 1,424.54 Net Block 4.54 6.94 19.25 23.65 63.91 76.28 14.98 4.60 5.71 6.48 Gross Block 9.08 28.36 38.92 40.71 74.81 85.08 23.93 12.09 10.82 9.87 Accumulated Depreciation 4.54 21.42 19.67 17.06 10.90 8.80 8.95 7.49 5.11 3.39 Non Current Assets 878.02 919.01 1,265.59 1,183.39 1,276.75 239.77 1,029.20 1,008.86 958.91 160.85 Capital Work in Progress 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.45 Non Current Investment 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 870.18 903.63 1,240.75 1,148.65 1,186.01 137.84 989.61 979.98 935.98 153.29 Other Non Current Assets 3.30 8.44 5.59 11.09 26.83 25.65 24.61 24.28 17.21 0.63 Current Assets 1,029.89 941.89 786.06 825.87 922.35 997.27 988.68 1,104.27 1,111.47 1,263.69 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 41.11 44.86 54.72 57.07 47.95 58.68 60.51 56.56 87.52 72.40 Sundry Debtors 40.14 41.47 36.16 44.56 38.73 37.60 45.59 43.91 40.83 50.17 Cash & Bank 648.03 596.08 555.94 517.63 498.88 581.91 612.02 775.08 815.72 1,125.55 Other Current Assets 300.61 2.04 15.95 15.49 336.79 319.08 270.56 228.72 167.40 15.57 Short Term Loans & Adv. 298.14 257.44 123.29 191.12 290.49 259.99 236.02 202.29 146.86 9.99 Net Current Assets 603.77 542.06 517.80 491.40 565.09 580.34 621.46 622.53 788.26 1,059.20 Total Assets 1,907.91 1,860.90 2,051.65 2,009.26 2,199.10 1,237.04 2,017.88 2,113.13 2,070.38 1,424.54

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 74.57 113.40 44.80 38.67 -69.21 -23.14 -194.28 160.99 -40.83 56.59 PBT 130.42 122.84 115.38 -3.82 40.04 28.64 85.77 157.52 91.73 111.37 Adjustment -38.80 -56.75 -48.92 -5.64 -4.98 -11.80 -72.66 -55.87 -55.95 -67.04 Changes in Working Capital -0.76 9.04 -24.00 66.72 -69.08 -1.85 -161.76 117.30 -32.45 91.70 Cash after chg. in Working capital 90.86 75.13 42.46 57.26 -34.02 14.99 -148.65 218.95 3.33 136.03 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -16.29 38.27 2.34 -18.59 -35.19 -38.13 -45.63 -57.96 -44.16 -79.44 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -3.31 33.13 -153.25 87.04 95.16 55.91 274.23 68.70 423.64 -630.47 Net Fixed Assets 19.28 10.56 1.79 34.10 10.27 -61.15 -11.84 -1.26 -0.51 15.76 Net Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 Others -22.59 22.57 -155.04 52.94 84.89 117.06 286.07 69.96 424.15 -646.24 Cash from Financing Activity -64.15 -120.99 -30.48 -35.63 -36.80 -41.41 -29.82 -267.65 -331.80 -38.57 Net Cash Inflow / Outflow 7.11 25.54 -138.93 90.08 -10.85 -8.64 50.13 -37.96 51.01 -612.45 Opening Cash & Equivalents 44.96 19.42 158.35 68.27 79.12 87.76 37.63 75.59 24.58 637.03 Closing Cash & Equivalent 52.07 44.96 19.42 158.35 68.27 79.12 87.76 37.63 75.59 24.58

Financial Ratios

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 318.06 301.79 314.30 281.17 289.36 293.36 309.34 299.76 329.45 375.63 ROA 5.35% 4.35% 5.09% -0.18% 1.22% 0.62% 2.51% 3.75% 3.27% 11.38% ROE 13.19% 11.21% 14.07% -0.53% 2.91% 1.36% 6.89% 9.40% 5.38% 18.01% ROCE 17.15% 16.35% 15.96% 0.14% 6.67% 4.73% 11.70% 19.72% 8.75% 24.77% Fixed Asset Turnover 20.84 10.90 10.39 8.43 5.68 9.77 32.72 59.76 63.43 38.38 Receivable days 38.18 38.62 35.62 31.23 30.70 28.50 27.72 22.59 25.31 35.20 Inventory Days 40.22 49.54 49.34 39.38 42.89 40.83 36.25 38.41 44.47 45.59 Payable days 101.73 110.74 119.32 130.52 159.09 74.34 84.28 68.27 44.09 50.69 Cash Conversion Cycle -23.33 -22.58 -34.36 -59.90 -85.49 -5.01 -20.31 -7.27 25.70 30.10 Total Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Interest Cover 170.38 83.44 66.93 0.21 6.21 5.48 54.94 29.48 128.40 1294.67

Top Investors:

investor education and protection fund (iepf)

Annual Reports:

News Update:

Novartis India - Quarterly Results
24th Jul 2026, 00:00 AM

Read More
Novartis India launches precision radiotherapy ‘Pluvicto’ for prostate cancer
15th Jun 2026, 15:59 PM

Pluvicto is the country's first regulatory authority-approved radioligand therapy for PSMA -positive prostate cancer
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback